When shall coronavirus disease-19 stop? Review of literature

Theodor Bilharz Research Institute

Bibliographic Information

Authors: El-Malky A.M.; Al-Kathiri W.H.; El Nouman A.A.

Journal: Open Access Macedonian Journal of Medical Sciences

Publisher: Open Access Macedonian Journal of Medical Sciences

Publication Date: 10 May 2020

Volume / Issue: Volume 8 / Issue T1

Pages: 75–81

ISSN: 18579655

DOI: 10.3889/oamjms.2020.4844

Scopus: View on Scopus

Document Type: Review

Access: All Open Access; Gold Open Access


Authors and Affiliations

El-Malky A.M., Morbidity and Mortality Unit Supervisor, King Saud Medical City, Riyadh, Saudi Arabia, Department of Public Health and Community Medicine, Theodor Bilharz Research Institute, Academy of Scientific Research, Ministry of Scientific Resarch, Cairo, Egypt; Al-Kathiri W.H., Department of Clinical Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; El Nouman A.A., Faculty of Medicine, Cairo University, Egypt


Abstract

In December 2019, a new coronavirus, now labeled as severe acute respiratory syndrome coronavirus 2, induced an episode of acute atypical respiratory illness started in Wuhan, Province of Hubei, China. The illness triggered by this virus was called coronavirus disease-19 (COVID-19). The infection is spread within humans and has triggered a global pandemic. The amount of death tolls continues to increase and a growing number of countries have been driven to create social barriers and lock-ups. The shortage of tailored counseling remains an issue. Epidemiological researches have shown that elderly patients are more vulnerable to serious diseases, while children tend to have milder symptoms. Here, we checked the latest understanding of this disease and found a possible explanation of the potential sequel and the expectations for the future. © 2020 Ahmed M. El-Malky, Waad H. Al-Kathiri, Azza A. El Nouman.


Keywords

Covid19; Economic; Medication; Pandemic; Political; Psychology; virus vaccine; coronavirus disease 2019; epidemic; herd immunity; human; panic; politics; Review; Severe acute respiratory syndrome coronavirus 2; universal precaution; virus mutation; World Health Organization


Citation Information

Scopus Citations: 2


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects